Sustaining the Rheumatology Research Enterprise

Por Davidson, Anne, Polsky, David
Publicado no Arthritis Care Res (Hoboken) (2015)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma

Por Polsky David, Osman Iman, Panageas Katherine S, Chang David Z, Busam Klaus, Chapman Paul B
Publicado em 2004-12-01

Clinical significance of BRAF mutations in metastatic melanoma

Por Chang, David Z, Panageas, Katherine S, Osman, Iman, Polsky, David, Busam, Klaus, Chapman, Paul B
Publicado em 2004

More Skin, More Sun, More Tan, More Melanoma

Por Chang, Caroline, Murzaku, Era Caterina, Penn, Lauren, Abbasi, Naheed R., Davis, Paula D., Berwick, Marianne, Polsky, David
Publicado em 2014

Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance

Por Penn, Lauren A., Qian, Meng, Zhang, Enhan, Ng, Elise, Shao, Yongzhao, Berwick, Marianne, Lazovich, DeAnn, Polsky, David
Publicado em 2014

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis

Por Weiss, Sarah, Darvishian, Farbod, Tadepalli, Jyothi, Shapiro, Richard, Golfinos, John, Pavlick, Anna, Polsky, David, Kirchhoff, Tomas, Osman, Iman
Publicado no BMC Cancer (2015)

Cooperative effects of INK4a and ras in melanoma susceptibility in vivo

Por Chin, Lynda, Pomerantz, Jason, Polsky, David, Jacobson, Mark, Cohen, Carlos, Cordon-Cardo, Carlos, Horner, James W., DePinho, Ronald A.
Publicado em 1997

Meta-Analysis of Sentinel Lymph Node Positivity in Thin Melanoma (≤ 1 mm)

Por Warycha, Melanie A., Zakrzewski, Jan, Ni, Quanhong, Shapiro, Richard L., Berman, Russell S., Pavlick, Anna C., Polsky, David, Mazumdar, Madhu, Osman, Iman
Publicado em 2009

Detection of Mutant BRAF Alleles in the Plasma of Patients with Metastatic Melanoma

Por Yancovitz, Molly, Yoon, Joanne, Mikhail, Maryann, Gai, Weiming, Shapiro, Richard L., Berman, Russell S., Pavlick, Anna C., Chapman, Paul B., Osman, Iman, Polsky, David
Publicado em 2007

Changes in the Presentation of Nodular and Superficial Spreading Melanomas Over 35 Years

Por Warycha, Melanie A., Christos, Paul J., Mazumdar, Madhu, Darvishian, Farbod, Shapiro, Richard L., Berman, Russell S., Pavlick, Anna C., Kopf, Alfred W., Polsky, David, Osman, Iman
Publicado em 2008

Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis

Por Hale, Christopher S., Qian, Meng, Ma, Michelle W., Scanlon, Patrick, Berman, Russell S., Shapiro, Richard L., Pavlick, Anna C., Shao, Yongzhao, Polsky, David, Osman, Iman, Darvishian, Farbod
Publicado em 2013

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma

Por Yancovitz, Molly, Litterman, Adam, Yoon, Joanne, Ng, Elise, Shapiro, Richard L., Berman, Russell S., Pavlick, Anna C., Darvishian, Farbod, Christos, Paul, Mazumdar, Madhu, Osman, Iman, Polsky, David
Publicado em 2012

Impact of age on management of primary melanoma patients

Por Fleming, Nathaniel H., Tian, Jiaying, Vega-Saenz de Miera, Eleazar, Gold, Heidi, Darvishian, Farbod, Pavlick, Anna C., Berman, Russell S., Shapiro, Richard L., Polsky, David, Osman, Iman
Publicado em 2013

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastasis and post-brain metastasis survival

Por Zakrzewski, Jan, Geraghty, Laurel N., Rose, Amy E., Christos, Paul J., Mazumdar, Madhu, Polsky, David, Shapiro, Richard, Berman, Russell, Darvishian, Farbod, Hernando, Eva, Pavlick, Anna, Osman, Iman
Publicado em 2010

A High Proliferative Index of Recurrent Melanoma Is Associated with Worse Survival

Por Tu, Ting J., Ma, Michelle W., Monni, Stefano, Rose, Amy E., Yee, Herman, Darvishian, Farbod, Polsky, David, Berman, Russell S., Shapiro, Richard L., Pavlick, Anna C., Mazumdar, Madhu, Osman, Iman
Publicado em 2011

Phosphorylated 4E-BP1 is Associated with Poor Survival in Melanoma

Por O’Reilly, Kathryn E., Warycha, Melanie, Davies, Michael A., Rodrik, Vanessa, Zhou, Xi K., Yee, Herman, Polsky, David, Pavlick, Anna C., Rosen, Neal, Bhardwaj, Nina, Mills, Gordon, Osman, Iman
Publicado em 2009

Sensitivity of plasma BRAF(mutant) and NRAS(mutant) cell‐free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non‐RECIST disease progression

Por Chang, Gregory A., Tadepalli, Jyothirmayee S., Shao, Yongzhao, Zhang, Yilong, Weiss, Sarah, Robinson, Eric, Spittle, Cindy, Furtado, Manohar, Shelton, Dawne N., Karlin-Neumann, George, Pavlick, Anna, Osman, Iman, Polsky, David
Publicado no Mol Oncol (2015)

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

Por Solit, David B., Osman, Iman, Polsky, David, Panageas, Katherine S., Daud, Adil, Goydos, James S., Teitcher, Jerrold, Wolchok, Jedd D., Germino, F. Joseph, Krown, Susan E., Coit, Daniel, Rosen, Neal, Chapman, Paul B.
Publicado em 2008

Melanoma risk loci as determinants of melanoma recurrence and survival

Por Rendleman, Justin, Shang, Shulian, Dominianni, Christine, Shields, Jerry F, Scanlon, Patrick, Adaniel, Christina, Desrichard, Alexis, Ma, Michelle, Shapiro, Richard, Berman, Russell, Pavlick, Anna, Polsky, David, Shao, Yongzhao, Osman, Iman, Kirchhoff, Tomas
Publicado no J Transl Med (2013)

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

Por Ott, Patrick A., Hamilton, Anne, Min, Christina, Safarzadeh-Amiri, Sara, Goldberg, Lauren, Yoon, Joanne, Yee, Herman, Buckley, Michael, Christos, Paul J., Wright, John J., Polsky, David, Osman, Iman, Liebes, Leonard, Pavlick, Anna C.
Publicado em 2010